Literature DB >> 15023138

Acute graft versus host disease following liver transplantation: the enemy within.

Anna L Taylor1, Paul Gibbs, J Andrew Bradley.   

Abstract

This article reviews acute graft vs. host disease (GVHD) as a complication of orthotopic liver transplantation (OLT). The incidence, presentation, clinical course and outcome of GVHD after OLT are summarized and the pathogenesis is discussed, drawing parallels with GVHD after allogeneic haematopoietic stem cell transplantation. Risk factors for GVHD after OLT are examined and the potential role of donor lymphocyte macrochimerism in the recipient peripheral blood as a diagnostic aid for GVHD is discussed. Finally, treatment of GVHD after OLT is reviewed with particular emphasis on the potential role of some of the newer biological agents.

Entities:  

Mesh：

Substances：

Year:  2004        PMID： 15023138     DOI： 10.1111/j.1600-6143.2004.00406.x

Source DB:  PubMed          Journal:  Am J Transplant        ISSN： 1600-6135            Impact factor:   8.086


  27 in total

Review 1.  Where are we at with short bowel syndrome and small bowel transplant.

Authors:  Baris Dogu Yildiz
Journal:  World J Transplant       Date:  2012-12-24

Review 2.  Graft Versus Host Disease After Liver Transplantation in Adults: A Case series, Review of Literature, and an Approach to Management.

Authors:  Arvind R Murali; Subhash Chandra; Zoe Stewart; Bruce R Blazar; Umar Farooq; M Nedim Ince; Jeffrey Dunkelberg
Journal:  Transplantation       Date:  2016-12       Impact factor: 4.939

3.  Graft versus host disease after liver transplantation: a case report.

Authors:  Peng-Ji Gao; Xi-Sheng Leng; Dong Wang; Guang-Ming Li; Lei Huang; Jie Gao; Ji-Ye Zhu
Journal:  Front Med China       Date:  2010-12-01

4.  Unsuccessful treatment of four patients with acute graft-vs-host disease after liver transplantation.

Authors:  Xiao-Bo Chen; Jie Yang; Ming-Qing Xu; Tian-Fu Wen; Lu-Nan Yan
Journal:  World J Gastroenterol       Date:  2012-01-07       Impact factor: 5.742

5.  Cenicriviroc ameliorates the severity of graft-versus-host disease through inhibition of CCR5 in a rat model of liver transplantation.

Authors:  Minhuan Li; Chenglin Lu; Hao Zhu; Xing Kang; Feng Wang; Lihua Shao; Xiaofeng Lu; Wei Chen; Xuefeng Xia
Journal:  Am J Transl Res       Date:  2019-06-15       Impact factor: 4.060

Review 6.  Graft-versus-host disease after liver transplantation: a comprehensive literature review.

Authors:  Sami Akbulut; Mehmet Yilmaz; Sezai Yilmaz
Journal:  World J Gastroenterol       Date:  2012-10-07       Impact factor: 5.742

Review 7.  Avoiding pitfalls: what an endoscopist should know in liver transplantation--part II.

Authors:  Sharad Sharma; Ahmet Gurakar; Cemalettin Camci; Nicolas Jabbour
Journal:  Dig Dis Sci       Date:  2008-12-17       Impact factor: 3.199

Review 8.  Immunological basis for treatment of graft versus host disease after liver transplant.

Authors:  Vikrant Rai; Nicholas Edward Dietz; Devendra K Agrawal
Journal:  Expert Rev Clin Immunol       Date:  2016-02-24       Impact factor: 4.473

9.  FISH diagnosis of acute graft-versus-host disease following living-related liver transplant.

Authors:  Kazunori Kanehira; Douglas L Riegert-Johnson; Dong Chen; Lawrence E Gibson; Stephen D Grinnell; Gopalrao V Velgaleti
Journal:  J Mol Diagn       Date:  2009-05-21       Impact factor: 5.568

Review 10.  Absence of peripheral blood chimerism in graft-vs-host disease following orthotopic liver transplantation: case report and review of the literature.

Authors:  Joshua M Schulman; Christina Yoon; Jennifer Schwarz; Parsia A Vagefi; Thaddeus W Mully; Kanade Shinkai
Journal:  Int J Dermatol       Date:  2013-12-30       Impact factor: 2.736
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.